Global Proteome Quantification for Discovering Imatinib-Induced Perturbation of Multiple Biological Pathways in K562 Human Chronic Myeloid Leukemia Cells

Journal of Proteome Research - United States
doi 10.1021/pr100814y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells

PLoS ONE
Multidisciplinary
2015English

Activin a Induction of Erythroid Differentiation Sensitizes K562 Chronic Myeloid Leukemia Cells to a Subtoxic Concentration of Imatinib

American Journal of Physiology - Cell Physiology
PhysiologyCell Biology
2014English

Adhesion to Stromal Cells Mediates Imatinib Resistance in Chronic Myeloid Leukemia Through ERK and BMP Signaling Pathways

Scientific Reports
Multidisciplinary
2017English

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients

2012English

Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Spautin-1, a Novel Autophagy Inhibitor, Enhances Imatinib-Induced Apoptosis in Chronic Myeloid Leukemia

International Journal of Oncology
Cancer ResearchOncology
2014English

Synergistic Effect of HMGB1 Knockdown and Cordycepin in the K562 Human Chronic Myeloid Leukemia Cell Line

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells

Oncology Reports
MedicineCancer ResearchOncology
2017English

Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?

ISRN Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy